|
🐜
|
Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.
11 auth.
R. D. de Latour,
J. Mary,
C. Salanoubat,
L. Terriou,
G. Étienne,
M. Mohty,
...
S. Roth,
S. de Guibert,
S. Maury,
J. Cahn,
G. Socié
|
8 |
2008 |
8
🐜
|
|
🐜
|
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.
17 auth.
G. Salles,
N. Mounier,
S. de Guibert,
F. Morschhauser,
C. Doyen,
J. Rossi,
C. Haioun,
P. Brice,
B. Mahé,
R. Bouabdallah,
...
B. Audhuy,
C. Fermé,
C. Dartigeas,
P. Feugier,
C. Sebban,
L. Xerri,
C. Foussard
|
8 |
2008 |
8
🐜
|
|
🐜
|
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
16 auth.
R. Kelly,
B. Höchsmann,
J. Szer,
A. Kulasekararaj,
S. de Guibert,
A. Röth,
I. Weitz,
E. Armstrong,
A. Risitano,
Christopher J. Patriquin,
...
L. Terriou,
P. Muus,
A. Hill,
M. Turner,
H. Schrezenmeier,
R. Peffault de Latour
|
7 |
2015 |
7
🐜
|
|
🐜
|
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study.
12 auth.
G. Cartron,
S. de Guibert,
M. Dilhuydy,
F. Morschhauser,
V. Leblond,
J. Dupuis,
...
B. Mahé,
R. Bouabdallah,
G. Lei,
M. Wenger,
Elisabeth Wassner-Fritsch,
M. Hallek
|
7 |
2014 |
7
🐜
|
|
🐜
|
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA‐4 expression
9 auth.
B. Birebent,
R. Lorho,
H. Lechartier,
S. de Guibert,
M. Alizadeh,
N. Vu,
...
Alain Beauplet,
N. Robillard,
G. Semana
|
7 |
2004 |
7
🐜
|
|
🐜
|
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study
27 auth.
M. Loschi,
R. Porcher,
F. Barraco,
L. Terriou,
M. Mohty,
S. de Guibert,
B. Mahé,
R. Lemal,
P. Dumas,
G. Étienne,
F. Jardin,
B. Royer,
D. Bordessoule,
P. Rohrlich,
L. Fornecker,
...
C. Salanoubat,
S. Maury,
J. Cahn,
L. Vincent,
T. Sené,
S. Rigaudeau,
S. Nguyen,
A. Lepretre,
J. Mary,
B. Corront,
G. Socié,
R. Peffault de Latour
|
7 |
2016 |
7
🐜
|
|
🐜
|
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma
27 auth.
O. Oluwole,
K. Bouabdallah,
J. Muñoz,
S. de Guibert,
J. Vose,
N. Bartlett,
Yi Lin,
A. Deol,
P. Mcsweeney,
A. Goy,
M. Kersten,
C. Jacobson,
U. Farooq,
M. Minnema,
C. Thieblemont,
...
J. Timmerman,
P. Stiff,
I. Avivi,
D. Tzachanis,
Jenny J. Kim,
Z. Bashir,
Jeff McLeroy,
Yan Zheng,
J. Rossi,
Lisa Johnson,
L. Goyal,
T. van Meerten
|
7 |
2021 |
7
🐜
|
|
🐜
|
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
15 auth.
R. D. de Latour,
H. Schrezenmeier,
A. Bacigalupo,
D. Blaise,
C. D. de Souza,
S. Vigouroux,
R. Willemze,
L. Terriou,
A. Tichelli,
M. Mohty,
...
S. de Guibert,
J. Marsh,
J. Passweg,
Jean Yves Mary,
G. Socié
|
6 |
2012 |
6
🐜
|
|
🐜
|
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
26 auth.
R. Guièze,
P. Robbe,
R. Clifford,
S. de Guibert,
Bruno Pereira,
A. Timbs,
M. Dilhuydy,
M. Cabes,
L. Ysebaert,
A. Burns,
F. Nguyen‐Khac,
F. Davi,
L. Véronèse,
P. Combes,
M. Le Garff-Tavernier,
...
V. Leblond,
H. Merle-Béral,
R. Alsolami,
A. Hamblin,
J. Mason,
A. Pettitt,
P. Hillmen,
Jenny C. Taylor,
S. Knight,
O. Tournilhac,
A. Schuh
|
6 |
2015 |
6
🐜
|
|
🐜
|
Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study
20 auth.
S. le Gouill,
S. de Guibert,
L. Planche,
P. Brice,
J. Dupuis,
G. Cartron,
A. van Hoof,
O. Casasnovas,
E. Gyan,
H. Tilly,
...
C. Fruchart,
E. Deconinck,
O. Fitoussi,
L. Gastaud,
V. Delwail,
J. Gabarre,
R. Gressin,
M. Blanc,
C. Foussard,
G. Salles
|
6 |
2011 |
6
🐜
|
